Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma.

MLA

Hanafy, Nemany A., et al. “Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma.” Nanomaterials (2079-4991), vol. 8, no. 1, Jan. 2018, p. 34. EBSCOhost, https://doi.org/10.3390/nano8010034.

APA

Hanafy, N. A., Dini, L., Citti, C., Cannazza, G., & Leporatti, S. (2018). Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma. Nanomaterials (2079-4991), 8(1), 34. https://doi.org/10.3390/nano8010034

Chicago

Hanafy, Nemany A., Luciana Dini, Cinzia Citti, Giuseppe Cannazza, and Stefano Leporatti. 2018. “Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma.” Nanomaterials (2079-4991) 8 (1): 34. doi:10.3390/nano8010034.